FOXCUT expression was found enhanced in Basal-Like Breast Cancers (BLBCs) but not in other non-basal like breast cancer subtypes, suggesting that FOXCUT may function as specific biomarker in BLBCs [53]. Here, FOXCUT is linked to breast cancer.